VUQUILSO Trademark

Trademark Overview

On Monday, November 15, 2021, a trademark application was filed for VUQUILSO with the United States Patent and Trademark Office. The USPTO has given the VUQUILSO trademark a serial number of 97125161. The federal status of this trademark filing is REGISTERED as of Tuesday, May 14, 2024. This trademark is owned by Glaxo Group Limited. The VUQUILSO trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
vuquilso

General Information

Serial Number97125161
Word MarkVUQUILSO
Filing DateMonday, November 15, 2021
Status700 - REGISTERED
Status DateTuesday, May 14, 2024
Registration Number7383698
Registration DateTuesday, May 14, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 27, 2024

Trademark Statements

Goods and ServicesVaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 19, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Thursday, November 18, 2021NEW APPLICATION ENTERED
Friday, November 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 25, 2022ASSIGNED TO EXAMINER
Tuesday, August 30, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 2, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, September 8, 2022ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, September 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 11, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 11, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 6, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 1, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 1, 2023SOU EXTENSION 1 FILED
Thursday, June 1, 2023SOU EXTENSION 1 GRANTED
Saturday, June 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 9, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 9, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 9, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 9, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 9, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 22, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 22, 2023SOU EXTENSION 2 FILED
Wednesday, November 22, 2023SOU EXTENSION 2 GRANTED
Friday, November 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 6, 2023TEAS PETITION TO AMEND BASIS RECEIVED
Wednesday, January 17, 2024ASSIGNED TO PETITION STAFF
Tuesday, January 23, 2024PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Tuesday, January 23, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, February 7, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 7, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 27, 2024PUBLISHED FOR OPPOSITION
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 14, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

vuquilso treatment preparations pharmaceutical diseases disorders hepatological respiratory genitourinary cardiopulmonary neurological